Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
Crossref DOI link: https://doi.org/10.1007/s40120-017-0084-6
Published Online: 2017-11-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saida, Takahiko
Yokoyama, Kazumasa
Sato, Ryusuke
Makioka, Haruki
Iizuka, Yukihiko
Hase, Masakazu
Ling, Yan
Torii, Shinichi